Warfarin Management During Linezolid Therapy

Understanding the Interaction and Management

The American College of Cardiology recommends that if INR rises to 4.5-9.0 without bleeding, warfarin should be held and oral vitamin K₁ 1-2.5 mg considered if patient has bleeding risk factors, then resumed at 20-30% lower weekly dose 1
The American College of Cardiology suggests that if INR exceeds 9.0 without bleeding, oral vitamin K₁ 3-5 mg should be administered and warfarin held until INR falls to therapeutic range, anticipating 24-48 hour response 1
In cases of highly unstable INR despite adjustments, the American College of Cardiology considers bridging to low-molecular-weight heparin during linezolid therapy, particularly in high-risk patients 2, 3

For patients requiring prolonged or repeated courses of linezolid, direct oral anticoagulants may be evaluated as alternatives to warfarin to avoid complex interactions, although this specific recommendation is not from a primary guideline society 4